Telavancin: a novel semisynthetic lipoglycopeptide agent to counter the challenge of resistant Gram-positive pathogens

Lignende værker

• Telavancin: A novel lipoglycopeptide antibiotic
  af: Damodaran, S. E., et al.
  Udgivet: (2011)
• New Gram-Positive Agents: the Next Generation of Oxazolidinones and Lipoglycopeptides
  af: Crotty, Matthew P., et al.
  Udgivet: (2016)
• Telavancin versus Vancomycin for Hospital-Acquired Pneumonia due to Gram-positive Pathogens
  af: Rubinstein, Ethan, et al.
  Udgivet: (2011)
• In Vitro Activity of Telavancin in Combination with Colistin versus Gram-Negative Bacterial Pathogens
  af: Hornsey, Michael, et al.
  Udgivet: (2012)
• In Vitro Activities of the New Semisynthetic Glycopeptide Telavancin (TD-6424), Vancomycin, Daptomycin, Linezolid, and Four Comparator Agents against Anaerobic Gram-Positive Species and Corynebacterium spp.
  af: Goldstein, Ellie J. C., et al.
  Udgivet: (2004)